Editorial: Antimycobacterial drug discovery: Molecular therapeutics and target identification. | Front Pharmacol;13: 997618, 2022. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Editorial: Antimycobacterial drug discovery: Molecular therapeutics and target identification.

Gunosewoyo, Hendra; Kruger, Gert.

Gunosewoyo H; Curtin Medical School, Faculty of Health Sciences, Curtin University, Perth, WA, Australia.
Kruger G; University of KwaZulu-Natal, Durban, South Africa.

Front Pharmacol ; 13: 997618, 2022.

Article in English | MEDLINE | ID: covidwho-2065613

Keywords

Mycobacterium abscessus; drug repurposing; mycobacterium; synergistic effects; tuberculosis

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Front Pharmacol Year: 2022 Document Type: Article Affiliation country: Fphar.2022.997618

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Front Pharmacol Year: 2022 Document Type: Article Affiliation country: Fphar.2022.997618